athenahealth, Inc. (NASDAQ:ATHN) had its price objective trimmed by KeyCorp from $170.00 to $140.00 in a research note released on Friday morning. The firm currently has an overweight rating on the health services provider’s stock.

A number of other analysts also recently weighed in on ATHN. SunTrust Banks, Inc. restated a buy rating and issued a $170.00 target price (up from $150.00) on shares of athenahealth in a report on Wednesday, August 2nd. Cowen and Company downgraded shares of athenahealth from an outperform rating to a market perform rating and boosted their target price for the stock from $127.00 to $133.00 in a report on Monday, July 31st. Cantor Fitzgerald restated a hold rating and issued a $145.00 target price on shares of athenahealth in a report on Friday. Jefferies Group LLC set a $110.00 target price on shares of athenahealth and gave the stock a hold rating in a report on Friday, October 13th. Finally, Morgan Stanley restated an equal weight rating and issued a $125.00 target price (up from $108.00) on shares of athenahealth in a report on Wednesday, August 2nd. Three research analysts have rated the stock with a sell rating, thirteen have given a hold rating and eleven have issued a buy rating to the company. The company has an average rating of Hold and an average price target of $147.83.

athenahealth (NASDAQ:ATHN) traded up 8.27% during mid-day trading on Friday, reaching $126.04. 3,213,267 shares of the company’s stock traded hands. The firm’s 50-day moving average price is $125.37 and its 200 day moving average price is $130.33. The firm has a market cap of $5.03 billion, a price-to-earnings ratio of 159.95 and a beta of 1.76. athenahealth has a one year low of $90.11 and a one year high of $158.66.

athenahealth (NASDAQ:ATHN) last posted its earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share for the quarter, topping analysts’ consensus estimates of $0.50 by $0.06. athenahealth had a net margin of 2.65% and a return on equity of 6.94%. The firm had revenue of $304.60 million for the quarter, compared to the consensus estimate of $310.52 million. During the same period in the previous year, the firm posted $0.60 EPS. The business’s quarterly revenue was up 10.1% on a year-over-year basis. On average, equities analysts forecast that athenahealth will post $1.91 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This report was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The original version of this report can be read at https://www.thecerbatgem.com/2017/10/21/athenahealth-inc-athn-given-new-140-00-price-target-at-keycorp.html.

In other athenahealth news, CEO Jonathan Bush sold 4,000 shares of the business’s stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $143.31, for a total value of $573,240.00. Following the completion of the sale, the chief executive officer now directly owns 319,807 shares of the company’s stock, valued at approximately $45,831,541.17. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Brandon H. Hull sold 800 shares of the business’s stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $140.01, for a total transaction of $112,008.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 15,783 shares of company stock valued at $2,132,924. 3.20% of the stock is owned by corporate insiders.

Institutional investors have recently added to or reduced their stakes in the business. Turner Investments LLC purchased a new stake in athenahealth in the 2nd quarter valued at about $105,000. Bessemer Group Inc. boosted its position in athenahealth by 13.7% in the 2nd quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock valued at $132,000 after buying an additional 113 shares during the period. FNY Partners Fund LP boosted its position in athenahealth by 1,900.0% in the 1st quarter. FNY Partners Fund LP now owns 1,000 shares of the health services provider’s stock valued at $112,000 after buying an additional 950 shares during the period. The Manufacturers Life Insurance Company boosted its position in athenahealth by 7.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock valued at $166,000 after buying an additional 84 shares during the period. Finally, Seven Bridges Advisors LLC boosted its position in athenahealth by 5.4% in the 2nd quarter. Seven Bridges Advisors LLC now owns 1,303 shares of the health services provider’s stock valued at $183,000 after buying an additional 67 shares during the period.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Stock Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related stocks with our FREE daily email newsletter.